PCSK9 (proprotein convertase subtilisin/kexin type 9) mRNARNA / oligonucleotide
Atherosclerotic Cardiovascular Disease
Upcoming events
(1 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share prices are end-of-day closes, delayed by 24 hours.